I agree there are downsides. But IB profits on IPOs are excessive and not mild like you'd expect of an insurance company. Hijacking the term "underwriting" is a

I agree there are downsides. But IB profits on IPOs are excessive and not mild like you'd expect of an insurance company. Hijacking the term "underwriting" is a bit dishonest.